Benjamin H. Durham

8.4k total citations · 1 hit paper
71 papers, 2.6k citations indexed

About

Benjamin H. Durham is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Benjamin H. Durham has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 26 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Benjamin H. Durham's work include Histiocytic Disorders and Treatments (28 papers), Mast cells and histamine (12 papers) and Acute Myeloid Leukemia Research (8 papers). Benjamin H. Durham is often cited by papers focused on Histiocytic Disorders and Treatments (28 papers), Mast cells and histamine (12 papers) and Acute Myeloid Leukemia Research (8 papers). Benjamin H. Durham collaborates with scholars based in United States, United Kingdom and France. Benjamin H. Durham's co-authors include Omar Abdel‐Wahab, Eli L. Diamond, J. Topping, Fraser Wd, Roy G. Farquharson, Alison J Black, William D. Fraser, Neval Özkaya, W.D. Fraser and Ahmet Doǧan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Benjamin H. Durham

68 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

2018 313 citations Jean‐François Emile, Benjamin H. Durham et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin H. Durham United States	28	1.3k	629	548	532	528	71	2.6k
Noboru Asada Japan	21	149 0.1×	571 0.9×	269 0.5×	176 0.3×	383 0.7×	89	2.2k
Monica L. Calicchio United States	15	681 0.5×	532 0.8×	243 0.4×	234 0.4×	342 0.6×	21	1.8k
Ralph Lachman United States	26	717 0.6×	840 1.3×	175 0.3×	44 0.1×	357 0.7×	68	2.8k
Hiroshi Kuroda Japan	27	172 0.1×	604 1.0×	1.1k 1.9×	62 0.1×	443 0.8×	107	2.5k
Nathalie Franchimont United States	31	173 0.1×	894 1.4×	286 0.5×	24 0.0×	670 1.3×	78	2.5k
Leonard O. Langer United States	31	250 0.2×	879 1.4×	184 0.3×	51 0.1×	329 0.6×	77	2.7k
Aline Martin United States	23	251 0.2×	1.0k 1.6×	484 0.9×	18 0.0×	381 0.7×	48	2.8k
Amanda K. Huber United States	26	168 0.1×	498 0.8×	354 0.6×	40 0.1×	264 0.5×	49	2.3k
Jin Sun Lee South Korea	28	165 0.1×	454 0.7×	119 0.2×	60 0.1×	758 1.4×	101	2.1k
Marina Colombi Italy	31	125 0.1×	1.1k 1.7×	441 0.8×	30 0.1×	478 0.9×	181	3.7k

Countries citing papers authored by Benjamin H. Durham

Since Specialization

Citations

This map shows the geographic impact of Benjamin H. Durham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin H. Durham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin H. Durham more than expected).

Fields of papers citing papers by Benjamin H. Durham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin H. Durham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin H. Durham. The network helps show where Benjamin H. Durham may publish in the future.

Co-authorship network of co-authors of Benjamin H. Durham

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin H. Durham. A scholar is included among the top collaborators of Benjamin H. Durham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin H. Durham. Benjamin H. Durham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durham, Benjamin H., et al.. (2025). Influence of ApoE genotype on doxorubicin-induced cognitive impairment in juvenile rats. Scientific Reports. 15(1). 44620–44620.

Salmon‐Divon, Mali, Ofer Shpilberg, Elimelech Okon, et al.. (2024). The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms. Leukemia. 39(2). 516–519. 2 indexed citations

Emile, Jean‐François, Zofia Hélias‐Rodzewicz, Benjamin H. Durham, et al.. (2023). Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type. Blood Advances. 7(23). 7254–7257. 4 indexed citations

Park, Jae H., Sean M. Devlin, Benjamin H. Durham, et al.. (2023). Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia. NEJM Evidence. 2(10). EVIDoa2300074–EVIDoa2300074. 8 indexed citations

Durham, Benjamin H., Oshrat Hershkovitz‐Rokah, Omar Abdel‐Wahab, et al.. (2023). Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood Advances. 7(23). 7319–7328. 7 indexed citations

Rampal, Raajit K., Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.. (2021). Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms. Clinical Cancer Research. 27(12). 3456–3468. 14 indexed citations

Wontakal, Sandeep N., Huan Zhang, Chengjie Gao, et al.. (2021). RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease. Blood. 139(9). 1413–1418. 9 indexed citations

Liu, Bo, Zhaoqi Liu, Sisi Chen, et al.. (2020). Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis. Journal of Clinical Investigation. 131(1). 28 indexed citations

Chakraborty, Rikhia, Omar Abdel‐Wahab, & Benjamin H. Durham. (2020). MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. Cold Spring Harbor Perspectives in Medicine. 11(5). a034892–a034892. 14 indexed citations

10.

Loizou, Evangelia, Ana Banito, Geulah Livshits, et al.. (2019). A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1. Cancer Discovery. 9(7). 962–979. 59 indexed citations

11.

Fei, Dennis Liang, Tao Zhen, Benjamin H. Durham, et al.. (2018). Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1. Proceedings of the National Academy of Sciences. 115(44). E10437–E10446. 58 indexed citations

12.

Zarnegar, Sara, Benjamin H. Durham, Pallavi Khattar, et al.. (2017). Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis. Pediatric Blood & Cancer. 65(1). 17 indexed citations

13.

Mass, Elvira, Christian E. Jacome-Galarza, Thomas Blank, et al.. (2017). A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Experimental Hematology. 53. S79–S79. 11 indexed citations

14.

Diamond, Eli L., Benjamin H. Durham, Ahmet Doǧan, et al.. (2017). Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders. Blood. 130. 257–257. 3 indexed citations

15.

Özkaya, Neval, Marc K. Rosenblum, Benjamin H. Durham, et al.. (2017). The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort. Modern Pathology. 31(4). 581–597. 91 indexed citations

16.

Sodi, Ravinder, et al.. (2009). The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism. Clinical Biochemistry. 42(13-14). 1375–1380. 24 indexed citations

17.

Huda, M. S. B., Benjamin H. Durham, Steve Wong, et al.. (2007). Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects. Bone. 41(3). 406–413. 27 indexed citations

18.

Fraser, W.D., Benjamin H. Durham, J. L. Berry, & E.B. Mawer. (1997). Measurement of Plasma 1,25 Dihydroxyvitamin D Using a Novel Immunoextraction Technique and Immunoassay with Iodine Labelled Vitamin D Tracer. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(6). 632–637. 59 indexed citations

19.

Rhodes, Lesley E., Benjamin H. Durham, W.D. Fraser, & PS Friedmann. (1994). Fish oil decreases UVB-induced prostaglandin E2 levels and increases the UVA-provocation threshold of polymorphic light eruption. Journal of Investigative Dermatology. 103(3). 404.

20.

Durham, Benjamin H.. (1976). Spectrophotometric end-point method for assay of serum cystyl-aminopeptidase in pregnancy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(1). 79–82. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact